Ligands to the 2Fe iron-sulfur center in succinate dehydrogenase  by Ævarsson, Arnthór & Hederstedt, Lars
Volume 232, number 2, 298-302 FEB 05852 May 1988 
Ligands to the 2Fe iron-sulfur center in succinate dehydrogenase 
Arnthbr Bvarsson and Lars Hederstedt 
Department of Microbiology, University of Lund, Siilvegatan 21, S-223 62 Lund, Sweden 
Received 1 March 1988 
Membrane-bound succinate oxidoreductases are flavoenzymes containing one each of a 2Fe, a 3Fe and a 4Fe iron-sulfur 
center. Amino acid sequence homologies indicate that all three centers are located in the Ip (B) subunit. From polypeptide 
and gene analysis of Bacillus subtillis succinate dehydrogenase-defective mutants combined with earlier EPR spectroscop- 
ic data, we show that four conserved cysteine residues in the first half of Ip are the ligands to the [2Fe-2S] center. These 
four residues have previously been predicted to be the ligands. Our results also suggest hat the N-terminal part of B. 
subtilis Ip constitutes adomain which can incorporate separately the 2Fe center and interact with Fp, the flavin-contain- 
ing subunit of the dehydrogenase. 
Structural mutant; Iron-sulfur protein; sdh gene; Succinate oxidoreductase; Nonsense mutation; (B. subtilis) 
1. INTRODUCTION 
Membrane-bound succinate dehydrogenase 
(SDH) and fumarate reductase (FRD) are iron- 
sulfur flavoenzymes (EC 1.3.99.1) which catalyse 
succinate-fumarate interconversion. Their chemi- 
cal composition and primary structure are con- 
served (cf. [l-5]). The catalytic part is a dimer 
with a 60-79 kDa and a 25-31 kDa protein 
subunit. One FAD is covalently bound to a 
histidine in the larger flavoprotein (Fp or A) 
subunit, whereas three iron-sulfur centers seem to 
be located in the smaller iron-protein (Ip or B) 
subunit. Studies mainly with mammalian SDH and 
Escherichia coli FRD have demonstrated the 
centers to be one [2Fe-2S], one [3Fe-xS] (where x 
is 3 or 4) and one [4Fe-4S] [1,6-91. 
The role of each prosthetic group in electron 
transfer between the dicarboxylate at the active site 
on Fp and the electron acceptor/donor component 
in the membrane is not known in detail [lO,ll]. 
Structural information on how the FAD and the 
iron-sulfur centers are arranged within the enzyme 
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is required in order to understand fully the 
assembly and the function of SDH and FRD. 
The complete amino acid sequence of Ip is 
available from E. coli FRD [12] and SDH [ 131, 
Bacillus subtilis SDH [14], bovine heart SDH [15] 
and Proteus vufgaris FRD [ 161. They contain 11 
(E. coli SDH only 10) cysteine residues at con- 
served positions distributed in three clusters 
designated I, II and III [1,13]. Based on amino 
acid sequence comparisons with less complex iron- 
sulfur proteins of known three-dimensional struc- 
ture, it has been proposed that the four cysteines of 
cluster I are ligands to the 2Fe center, whereas 
clusters II and III would ligate the 3Fe and 4Fe 
centers [1,17]. Herein we present experimental 
evidence from B. subtilis mutant SDH for the liga- 
tion of the 2Fe center to the cysteine residues of 
cluster I. 
The 2Fe, 3Fe and 4Fe centers have been 
demonstrated in B. subtilis SDH and are called 
S-l, S-3 and S-2, respectively [l&19]. EPR spec- 
troscopy of B. subtilis mutants defective in Ip 
showed that center S-l can be assembled in soluble 
SDH, provided that the mutant contained Fp and 
a fragment of about 15 kDa or larger of Ip [ 181. 
Wild-type Ip has a molecular mass of 28 kDa. 
From these previous results it could not be unam- 
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biguously concluded whether the Ip fragments in 
the mutants were truncated polypeptides resulting 
from nonsense mutations or were proteolytic 
degradation products from a full-length mutant 
Ip. We have now analysed Ip polypeptides from 
four mutants, mapped the respective mutations in 
the structural gene for Ip, sdhB, and identified one 
mutation by DNA sequence analysis. The results 
together with previous EPR data show that SDH 
with a truncated Ip lacking cysteine clusters II and 
III can still ligate iron-sulfur center S-l. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains, plasmids and phages 
The origin and Sdh phenotype of B. subtilis mutants 
KA94109 (sdhCIO9, ilvB2), KA97083 (sdhB83, trpC2, ieu-2), 
KA99103 (sdhBI03, ieu-2), KA97118 (sdhBZ18, trpC2, Ieu-2) 
and KA99123 (sdhB123, leu-2) have been described in 1201. 
KA99103 and KA99123 are Trp+ derivatives of strains KA97103 
and KA97123. The B. subtihs sdhC, sdhA and sdhB genes en- 
coding cytochrome b-558, Fp and Ip were until 1987 designated 
sdhA, sdhB and sdhC, respectively [14]. E. coli JM83 (ara, 
A(lac-proAB), rpsL, e580, lacZAM15) [21] and SK (hsdR, thi, 
thr, rpsL, lacz) [22] were used for plasmid production. E. coli 
JMlOl (supE, thi, A(iac-proAd), [F’, traD36, proAB, 
lacPZAMlS]) and E. coli JM103 (thi, rpsL, sbcBI5, endA, 
hspR4, SUPE A(lac-proAB), [F’, traD36, proAB, 
lacPZAMlS]) were the hosts for propagation of bacteriophages 
Ml3 mp18 and Ml3 mp19 and recombinants thereof [21]. 
Plasmids pSH1047 (sdhC sdhA sdhB gerE) [23], pSDHA12 
(sdhB) [24] and pUC18 and pUC19 [21] have been described 
before. pLUW1 is pUC18 into which the 4.5 kbp sdhAB PstI 
fragment of pSH1047 has been inserted. Integration vector 
pLUW3 is a 6.3 kbp derivative of pN01523 [25] containing the 
kan gene of pUBll0 [26] and a 395 bp UindIII-PvuII B. subtilis 
DNA fragment (ORF2) from the region just downstream of 
sdhB (fig.2). 
2.2. Growth media and transformation 
E. coli JM strains and strain 5K were made competent by 
CaC12 treatment [27] and by the method of Hanahan [28], 
respectively. B. subtilis was grown to competence as described 
by Arwert and Venema [29], except hat the cells were grown at 
37°C for 4.5 instead of 3.5 h. E. colt’ transformants were 
selected on LA plates with ampicillin (35 mg/l). B. subtihs 
kanamycin-resistant transformants were selected on tryptose 
blood agar base (Difco, USA) plates containing kanamycin 
sulfate (5 mg/l). Sdh+ transformants were selected on minimal 
citrate/glutamate plates [30]. 
2.3. In vitro DNA techniques 
Plasmid DNA was isolated according to the procedure of Ish- 
Horowitz and Burke [31]. B. subtilis chromosomal DNA was 
isolated as described for plasmid DNA by Canosi et al. [32]. 
Restriction endonuclease digestions, agarose gel electrophoresis 
and ligation with bacteriophage T4 DNA ligase followed stan- 
dard methods [33]. DNA fragments were generally isolated 
from agarose gels using Geneclean (BIO 101, USA). Propaga- 
tion of bacteriophage Ml3 and isolation of single-stranded 
DNA were carried out according to Messing [34]. DNA se- 
quence analyses were performed using the dideoxy chain- 
termination method [35] with modified T7 DNA polymerase 
1361. 
3. RESULTS 
3.1. IP antigen in mutants 
B. subtilis mutants KA97083, KA99103, 
KA97118 and KA99123 lack SDH activity, have 
normal Fp subunits in the cytoplasm and are defec- 
tive in Ip due to mutations in the sdhB gene [20]. 
With the exception of KA99123, they contain iron- 
sulfur center S-l as determined by EPR spec- 
troscopy of cell-free extracts [ 181. The mutants and 
a reference strain KA94109 (mutant with 
cytoplasmic wild-type Fp and Ip subunits) were 
analysed with respect to the Ip subunit. Extracts 
were immunoadsorbed with anti-Ip antibodies and 
the antigens were then run in SDS-polyacrylamide 
gel electrophoresis (fig. 1). 
The wild-type Ip from KA94109 appeared as a 
doublet band with an apparent molecular mass of 
28 kDa. Mutants KA99103 and KA97118 con- 
tained a distinct single Ip antigen of approx. 
16 kDa (fig.1, lanes B,C), whereas KA97083 had 
an antigen .of about 19 kDa (lane E). Strain 
KA99123 lacked detectable Ip (lane D). Full-length 
Ip was not found in any of the mutants. A trace of 
28 kDa Ip antigen has however been detected in 
KA99123 cell extracts using immunoblot analysis 
(Schrdder, I., unpublished). 
3.2. Genetic mapping of sdhB mutations 
The sdhB mutation in each mutant was mapped 
by transformation with overlapping wild-type B. 
subtilis DNA fragments corresponding to the sdhB 
region of the chromosome. The DNA fragments 
used and the results of the experiments are shown 
in fig.2. 
Mutations sdhB103 and sdhBIl8 which both 
result in an about 16 kDa Ip antigen, mapped to a 
200 bp DraI-Hind111 fragment from the middle 
part of sdhB. The two mutations are possibly iden- 
tical. Mutation sdhB83 has previously been map- 
ped to a location distal to sdhBIO3 [20] and 
upstream of the NarI site at nucleotide 3245 in 
sdhB [37]. The Hind111 fragment of subclone 
pSDHB45 carried the wild-type allele of sdhB83. 
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Fig. 1. Ip- antigens immunoadsorbed from [“Slmethionine- 
labeled mutant B. subtilis cell lysates and analyzed by SDS- 
polyacrylamide (lO-15% acrylamide) gel electrophoresis. An 
autoradiograph of the gel is shown. Preparation of cell lysates, 
immunoadsorption using protein A-Sepharose 4B-Cl and 
electrophoresis were performed as in 114). A, KA94109 (wild- 
type Ip); B, KA99103 (sdhBIO3); C, KA97118 (sdhB118); D, 
KA99123 (sdhB123); E, KA97083 (sdhB83). 
From these results we conclude that s&B83 is 
located on an 86 bp fragment flanked by 
nucleotides 3159 and 3245. Mutation sdhB123 
seems to be located close to the DraI site in sdhB, 
because it could only be rescued by DNA with this 
site intact. Alternatively, sdhBZ23 is two muta- 
tions, one on each side of the DraI site (fig.2). 
3.3. sdhB103 is a nonsense mutation 
The location of mutation sdhBZ03 in the struc- 
tural gene for the Ip polypeptide and the size of the 
resulting Ip antigen strongly suggested that a stop 
codon has been introduced, leading to a truncated 
gene product. To confirm this and to map the ex- 
act location of the mutation we cloned sdhB from 
KA99103 and determined the nucleotide sequence 
of the mutated DNA fragment. The cloning was 
performed with the use of integration vector 
pLUW3 essentially by the same technique as 
described previously for the isolation of sdhC mu- 
tant genes [30]. Plasmid pSDHB103 was generated 
from EcoRI-digested KA99103::pLUW3 chromo- 
somal DNA. The plasmid contained the mutant 
sdhB gene and 1 kbp of sdhA . 
Donor DNA. 
rdh B mutation 
83 103 118 I23 
pSDHAS34 [ I I - + + + 
PSDHE45 I +--- 
pSDHAS3404 17 - - - 
&xSD”AS3403 -3 - - - 
pSDHE3437 I I + + + 
PSDHS3447 I + + - 
r I I 
0 05 1.0 kb 
Fig.2. Map of the sdh region in B. subtilis and mapping of sdhB 
mutations. The DNA fragments hown in the lower part were 
isolated from pLUW1 or pSDHA12 and cloned into pUC18 or 
pUC19. B. subtilis with the indicated sdhB mutations was then 
transformed with saturating amounts of the purified plasmids 
and Sdh+ transformants were selected (+ , transformants; - , 
no transformants). Relevant endonuclease restriction sites are 
indicated; D, Dral; E, EcoRI; II, HindlII; N, NurI; Pv, PvuII. 
The short arrow just before sdhC shows the start-point and 
direction of transcription of the sdh operon. 
The 200 bp DraI-Hind111 fragment (see fig.2) of 
pSDHB103 was subcloned in phage Ml3 and the 
complete nucleotide sequence of both strands was 
determined. Only one base pair change was found 
compared to the wild-type sequence [14]. The G to 
A substitution at nucleotide 3 113 changes a tryp- 
tophan codon to an UGA stop codon. The 
predicted product from this mutant sdhB gene is a 
truncated Ip polypeptide, 146 amino acid residues 
long and with a calculated mass of 16841 Da, the 
initiation methionine excluded [38]. 
4. DISCUSSION 
Iron-sulfur centers in proteins are usually ligated 
to cysteine residues, however, a non-cysteine 
residue like histidine can also function as a ligand 
[17,39]. The 2Fe center in succinate oxidoreduc- 
tases is most likely ligated to four cysteine residues 
in the Ip subunit. 
A successful separation of SDH into Fp and Ip, 
without destruction of the center has not been 
reported. The ligands to the 2Fe center S-l have 
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tentatively been identified from the following 
observations: (i) Fp does not contain cysteine 
residues that are conserved in all succinate ox- 
idoreductases [1,14]. (ii) The 2Fe center of 
Wolinella (Vibrio) succinogenes FRD is associated 
with the 31 kDa subunit as determined by EPR 
spectroscopy of the resolved enzyme [40]. (iii) B. 
subtilis mutant KA99123 (sdhBZ23) contains func- 
tional Fp but lacks detectable amounts of Ip and 
the center S-l [18]. (iv) The ligands to center S-l in 
mammalian SDH are, as determined by the elec- 
tron spin echo envelope modulation technique, 
probably four cysteine residues [41]. (v) The spac- 
ing between the four conserved cysteines of cluster 
I in Ip is, as pointed out by several authors, very 
similar to that of the ligands to 2Fe centers in 
plant-type ferredoxins [ 1,171. 
B. subtilis mutant KA99103 (s&BZW) contains 
center S-l and was shown in this work to syn- 
thesize a truncated Ip polypeptide of 16.8 kDa. 
The shortened Ip has only four cysteine residues 
and lacks histidine residues. These experimental 
findings combined with the observations listed 
above strongly suggest hat the [2Fe-2S] center in 
B. subtilis SDH is ligated to the Ip polypeptide by 
the cysteine residues at positions 63, 68, 71 and 83 
(fig.3). 
Mutation sdhB83 is probably also a nonsense 
mutation, since it maps in a sequence of sdhB en- 
coding amino acid residues 163-191 and cell 
lysates of KA97083 contain an Ip fragment of 
about 19 kDa (fig. 1). The size of the fragment cor- 
responds to a polypeptide of about 180 residues. 
This truncated Ip would contain all the cysteine 
I 
ccc c 
residues of cluster I and probably all four cysteine 
residues of cluster II (fig.3). These properties of 
KA97083 and the fact that center S-l is present in 
this mutant can be useful in studies on the role of 
the cluster II cysteines in ligation of centers S-2 and 
s-3. 
Studies on B. subtilis SDH-defective mutants in- 
dicate that Ip in the cytoplasm is stabilized by 
association with Fp [18]. In the absence of func- 
tional Fp, the Ip polypeptide (wild-type and mu- 
tant alike) is rapidly degraded in cell lysates. 
Mutants KA99103 and KA97083 contain, in con- 
trast to KA99123, relatively stable Ip fragments 
with center S-l incorporated. Apparently, the N- 
terminal 146 residues of Ip can separately form a 
domain which contains only one of the three iron- 
sulfur centers of SDH and is still able to associate 
with Fp. However, Fp associated with this domain 
of Ip cannot be bound to cytochrome b-558, the 
anchor protein and electron acceptor for SDH in 
the B. subtilis cytoplasmic membrane [30]. Center 
S-3 is most likely ligated to cysteine residues in the 
C-terminal half of Ip. An intact center S-3 is re- 
quired for membrane binding of mammalian SDH 
[42]. Seemingly, the C-terminal part of Ip contains 
(part of) the structures that specifically can 
recognize and bind to the membrane anchor 
protein(s). 
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Fig.3. Schematic illustration of the B. subtilis Ip polypeptide showing the location of cysteine residues, mapped mutations and the 
effect of nonsense mutation sdhB103. The four conserved cysteine residues of cluster I are concluded to be the ligands to the [2Fe-2S] 
center in SDH. 
301 
Volume 232, number 2 FEBS LETTERS May 1988 
REFERENCES 
HI 
PI 
t31 
I41 
151 
[61 
I71 
181 
PI 
HOI 
IllI 
WI 
[I31 
H41 
1151 
WI 
v71 
D81 
WI 
P91 
Ohnishi, T. (1987) Curr. Top. Bioenerg. 15, 37-65. 
Hatefi, Y. (1985) Annu. Rev. Biochem. 54, 1015-1069. 
Cole, ST., Condon, C., Lemire, B.D. and Weiner, J.H. 
(1985) Biochim. Biophys. Acta 135, 381-403. 
Burke, J. J., Siedow, J.N. and Moreland, D.E. (1982) 
Plant Physiol. 70, 1577-1581. 
Samain, E., Patil, D.S., DerVartanian, D.V., Albagnac, 
G. and LeGall, J. (1987) FEBS Lett. 216, 140-144. 
Johnson, M.K., Morningstar, J.E., Bennett, D.E., 
Ackrell, B.A.C. and Kearney, E.B. (1985) J. Biol. Chem. 
260, 7368-7378. 
Maguire, J.J., Johnson, M.K., Morningstar, J.E., 
Ackrell, B.A.C. and Kearney, E.B. (1985) J. Biol. Chem. 
260, 10909-10912. 
Mormngstar, J.E., Johnson, M.K., Cecchini, G., 
Ackrell, B.A.C. and Kearney, E.B. (1985) J. Biol. Chem. 
260, 13631-13638. 
Cammack, R., Patil, D.S. and Weiner, J.H. (1986) Bio- 
chim. Biophys. Acta 870, 545-551. 
Cammack, R., Maguire, J.J. and Ackrell, B.A.C. (1988) 
in: Cytochrome Systems. Molecular Biology and 
Bioenergetics (Papa, S. ed.) Plenum, New York, in press. 
Singer, T.P. and Johnson, M.K. (1985) FEBS Lett. 190, 
189-198. 
Cole, S.T., Grundstrom, T., Jaurin, B., Robinson, J.J. 
and Weiner, J.H. (1982) Eur. J. Biochem. 126, 211-216. 
Darlison, M.G. and Guest, J.R. (1984) Biochem. J. 223, 
507-517. 
Phillips, M.K., Hederstedt, L., Hasnain, S., Rutberg, L. 
and Guest, J.R. (1987) J. Bacterial. 169, 864-873. 
Yao, Y., Wakabayashi, S., Matsuda, S., Matsubara, H., 
Yu, L. and Yu, C.-A. (1986) in: Iron-Sulfur Protein 
Research (Matsubara, H. et al. eds) pp.240-244, 
Springer, Tokyo. 
Cole, S.T. (1987) Eur. J. Biochem. 167, 481-488. 
Cammack, R. (1983) Chem. Ser. 21, 87-95. 
Hederstedt, L., Maguire, J. J., Waring, A.J. and Ohnishi, 
T. (1985) J. Biol. Chem. 260, 5554-5562. 
Maguire, J.J., Magnusson, K. and Hederstedt, L. (1986) 
Biochemistry 25, 5202-5208. 
Hederstedt, L., Magnusson, K. and Rutberg, L. (1982) J. 
Bacterial. 152, 157-165. 
WI 
WI 
1231 
1241 
1251 
[=I 
[271 
WI 
WI 
1301 
1311 
1321 
[331 
[341 
[351 
1361 
I371 
1381 
1391 
1401 
1411 
[421 
Yanisch-Perron, C., Viera, J. and Messing, J. (1985) 
Gene 33, 103-119. 
Hubacek, J. and Glover, S.W. (1970) J. Mol. Biol. 50, 
111-127. 
Hasnain, S., Sammons, R., Roberts, I. and Thomas, 
C.M. (1985) J. Gen. Microbial. 131, 2269-2279. 
Friden, H., Hederstedt, L. and Rutberg, L. (1987) FEMS 
Microbial. Lett. 41, 203-206. 
Dean, D. (1981) Gene 15, 99-102. 
Gryczan, T.J., Contente, S. and Dubnau, D. (1978) J. 
Bacterial. 134, 318-329. 
Cohen, S.N., Chang, C.Y. and Hsu, L. (1972) Proc. Natl. 
Acad. Sci. USA 69, 2110-2114. 
Hanahan, D. (1983) J. Mol. Biol. 166, 557-580. 
Arwert, F. and Venema, G. (1973) Mol. Gen. Genet. 123, 
185-198. 
Friden, H., Rutberg, L., Magnusson, K. and Hederstedt, 
L. (1987) Eur. J. Biochem. 168, 695-701. 
Ish-Horowitz, D. and Burke, J.F. (1981) Nucleic Acids 
Res. 9, 2989-2998. 
Canosi, U., Morelli, G. and Trautner, T.A. (1978) Mol. 
Gen. Genet. 166, 259-267. 
Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) 
Molecular Cloning. A Laboratory Manual, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, NY. 
Messing, J. (1983) Methods Enzymol. 101, 20-78. 
Sanger, F., Nicklen, S. and Coulson, A.R. (1977) Proc. 
Natl. Acad. Sci. USA 74, 5463-5467. 
Tabor, S. and Richardson, C.C. (1987) Proc. Natl. Acad. 
Sci. USA 84, 4767-477 1. 
Cutting, S. and Mandelstam, J. (1986) J. Gen. Microbial. 
132, 3013-3024. 
Hederstedt, L., Bergman, T. and Jornvall, H. (1987) 
FEBS Lett. 213, 385-390. 
Cline, J.F., Hoffman, B.M., Mims, W.B., Lattaie, E., 
Ballou, D.P. and Fee, J.A. (1985) J. Biol. Chem. 260, 
3251-3254. 
Albracht, S.P.J., Unden, G. and Kroger, A. (1981) Bio- 
chim. Biophys. Acta 661, 295-302. 
LoBrutto, R., Haley, P.E., Yu, C.-A. and Ohnishi, T. 
(1987) in: Advances in Membrane Biochemistry and 
Bioenergetics (Kim, C.H. et al. eds) pp.449-559, Plenum, 
New York. 
Vinogradov, A.D., Ackrell, B.A.C. and Singer, T.P. 
(1975) Biochem. Biophys. Res. Commun. 67, 803-809. 
302 
